Product/Composition:- | Albendazole tablets |
---|---|
Strength:- | 200 mg |
Form:- | Tablets |
Reference Brands:- | Albenza(US & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Albendazole inhibits parasite beta-tubulin, disrupting microtubule formation essential for energy production and cell division. It is effective against various helminths, including roundworms and tapeworms. Benefits include rapid parasitic eradication, broad-spectrum activity, oral convenience, and a good safety profile when used as prescribed, making it essential in antiparasitic therapy.
Albendazole tablets are approved in the EU and US for treating parasitic infections such as neurocysticercosis and echinococcosis. In the EU, brands like Albenza (by GSK) are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality standards. In the US, FDA approval is based on comprehensive clinical data; generic formulations are widely available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert support with regulatory dossiers and compliance, visit PharmaTradz. We facilitate seamless market access for albendazole, ensuring adherence to European and US standards for safe, effective antiparasitic therapy.